SNPs with proven functional effect and clinical relevance for the response to the following anticancer drugs: 5-Fluorouracyl, Doxorubicin, Metothrexate, Etoposide, 6-Mercaptopurine, Azothiopurin, Thioguanine, Irinotekan are studied in this project. The high precision genotyping of these SNPs is performed on the Nanogen platform. Genotyping on the Nanogen platform involves attachment of a biotinylated PCR product to a chip coated with hydrogel enriched with streptavidin, which is addressed by a stabilizer and a fluorescent labelled probe reporting for each of the variant alleles.
Figure A. Principle of SNP detection with the Nanogen system. Genotyping involves attaching a biotinylated PCR product to a streptavidin coated chip. A fluorescent probe that reports the respective allele is addressed to the amplicon. Alternatively, the probe can be attached to the solid surface and addressed by the PCR product (click to enlarge).
Key members: Silje Nordgard og Grethe I. Grenaker Alnæs
Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, Jiang X, O'Mara TA, Zhao N, Bolla MK, Dunning AM, Dennis J, Wang Q, Ful ZA, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Arun BK, Auer PL, Azzollini J, Barrowdale D, Becher H, Beckmann MWet al.(2020) Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses Nat Genet(in press) DOI 10.1038/s41588-020-0609-2, PubMed 32424353
Egeland NG, Jonsdottir K, Aure MR, Sahlberg K, Kristensen VN, Cronin-Fenton D, Skaland I, Gudlaugsson E, Baak JPA, Janssen EAM(2020) MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers BMC Cancer, 20(1), 377 DOI 10.1186/s12885-020-06857-7, PubMed 32370743
Pladsen AV, Nilsen G, Rueda OM, Aure MR, Borgan Ø, Liestøl K, Vitelli V, Frigessi A, Langerød A, Mathelier A, OSBREAC, Engebråten O, Kristensen V, Wedge DC, Van Loo P, Caldas C, Børresen-Dale AL, Russnes HG, Lingjærde OC(2020) DNA copy number motifs are strong and independent predictors of survival in breast cancer Commun Biol, 3(1), 153 DOI 10.1038/s42003-020-0884-6, PubMed 32242091